45%) and a favorable trend in OS (5-year OS 66% vs. 57%; HR 0.68, 95% CI 0.46–1.00) [ 8 , 9 ].
← all excerpts
Perioperative Chemotherapy in Bladder and Upper Tract Urothelial Carcinoma: Outcomes by Nodal Status and Lymphovascular Invasion.
1
—
—
45%) and a favorable trend in OS (5-year OS 66% vs. 57%; HR 0.68, 95% CI 0.46–1.00) [ 8 , 9 ].